Early research (Phase 1)Study completedNCT00073944What this trial is testingBCX-1777 in Treating Patients With Refractory CancerWho this might be right forCancer BioCryst Pharmaceuticals
Testing effectiveness (Phase 2)Ended earlyNCT00923247What this trial is testingA Targeted Phase I/II Trial of ZD6474 (Vandetanib; ZACTIMA) Plus the Proteasome Inhibitor, Bortezomib (Velcade ), in Adults With Solid Tumors With a Focus on Hereditary or Sporadic, Locally Advanced or Metastatic Medullary Thyroid Cancer (MTC)Who this might be right forMedullary Thyroid Carcinoma National Cancer Institute (NCI) 22
Early research (Phase 1)Looking for participantsNCT03093909What this trial is testingStudy of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary MetastasesWho this might be right forMalignant Neoplasm of Bone and Articular CartilageMalignant Neoplasms of Female Genital OrgansMalignant Neoplasms of Independent (Primary) Multiple Sites+7 more M.D. Anderson Cancer Center 44
Early research (Phase 1)Looking for participantsNCT04038619What this trial is testingFecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer PatientsWho this might be right forColitisDiarrheaMalignant Genitourinary System Neoplasm+6 more M.D. Anderson Cancer Center 40
Testing effectiveness (Phase 2)Ended earlyNCT01374451What this trial is testingEfficacy of Everolimus Alone or in Combination With Pasireotide LAR in Advanced PNETWho this might be right forIslet Cell Tumor Novartis Pharmaceuticals 160
Early research (Phase 1)Looking for participantsNCT06910657What this trial is testingIDOV-Immune for Advanced Solid TumorsWho this might be right forColorectal CancerPancreatic CancerMelanoma+13 more ViroMissile, Inc. 78
Early research (Phase 1)Ended earlyNCT05831995What this trial is testingSafety and Effectiveness of ABM-168 in Adults with Advanced Solid Tumors.Who this might be right forAdvanced Solid TumorRAS MutationRAF Mutation+1 more ABM Therapeutics Corporation 12
Not applicableUnknownNCT04336839What this trial is testingPortal Vein Resection in Pancreatic Neuroendocrine TumoursWho this might be right forPancreas NeoplasmNeuroendocrine Tumors Royal Free Hospital NHS Foundation Trust 40
Not applicableWithdrawnNCT04034745What this trial is testingOpen Label Study to Analyze the Effect of Telotristat Ethyl on Weight Regulation/GainWho this might be right forPancreatic CancerNeuroendocrine TumorsCachexia; Cancer Andrew Hendifar, MD
Not applicableStudy completedNCT02685631What this trial is testingYttrium Y 90 Resin Microspheres Data Collection in Unresectable Liver Cancer: the RESIN StudyWho this might be right forLocalized Non-Resectable Adult Liver Carcinoma Vanderbilt-Ingram Cancer Center 1,653
Testing effectiveness (Phase 2)Study completedNCT04400474What this trial is testingTrial of Cabozantinib Plus Atezolizumab in Advanced and Progressive Neoplasms of the Endocrine System. The CABATEN StudyWho this might be right forNeuroendocrine TumorAnaplastic Thyroid CancerAdenocarcinoma+2 more Grupo Espanol de Tumores Neuroendocrinos 93
Not applicableLooking for participantsNCT03160274What this trial is testingGenetic Analysis of Pheochromocytomas, Paragangliomas and Associated ConditionsWho this might be right forPheochromocytomaParagangliomaInherited Cancer Syndrome+5 more The University of Texas Health Science Center at San Antonio 2,000
Early research (Phase 1)Study completedNCT00451880What this trial is testingStudy of XL281 in Adults With Solid TumorsWho this might be right forCancerNon-small-cell Lung CancerColorectal Cancer+2 more Exelixis 180
Not applicableAvailableNCT06751524What this trial is testingExpanded Access Program (EAP) Designed to Provide Access to Botensilimab and Balstilimab Before Regulatory ApprovalWho this might be right forColorectal Cancer (CRC)Pancreatic CancerNon-Small Cell Lung Cancer (NSCLC)+5 more Agenus Inc.
Testing effectiveness (Phase 2)Study completedNCT00019786What this trial is testingIsolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver MetastasesWho this might be right forColorectal CancerIslet Cell TumorLiver Cancer+2 more National Institutes of Health Clinical Center (CC) 67
Early research (Phase 1)Looking for participantsNCT03454035What this trial is testingUlixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid TumorsWho this might be right forTumor, SolidPancreatic CancerMelanoma UNC Lineberger Comprehensive Cancer Center 45
Early research (Phase 1)Ended earlyNCT00039091What this trial is testingMonoclonal Antibody Therapy in Treating Patients With Ovarian Epithelial Cancer, Melanoma, Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Non-Small Cell Lung CancerWho this might be right forAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)+11 more National Cancer Institute (NCI) 26
Early research (Phase 1)Active Not RecruitingNCT05215574What this trial is testingStudy of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid TumorsWho this might be right forPancreatic CancerBreast CancerGastric Cancer+13 more NGM Biopharmaceuticals, Inc 130
Not applicableStudy completedNCT02330497What this trial is testingEfficacy and Safety of Radiofrequency Ablation in Pancreatic Neuroendocrine and Cystic TumorWho this might be right forPancreatic TumorEndocrine TumorNeoplasms, Cystic, Mucinous, and Serous Société Française d'Endoscopie Digestive 30
Not applicableStudy completedNCT05697198What this trial is testingPRospective REgistry of Advanced Stage CancER (PREFER) Patients to Assess Prevalence of Actionable Biomarkers and Driver Mutations to Address Disparities in Precision MedicineWho this might be right forLung CancerOvarian CancerUterine Cancer+10 more Labcorp Corporation of America Holdings, Inc 1,429